These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 30662298

  • 1. Ginsenoside compound K protects human umbilical vein endothelial cells against oxidized low-density lipoprotein-induced injury via inhibition of nuclear factor-κB, p38, and JNK MAPK pathways.
    Lu S, Luo Y, Zhou P, Yang K, Sun G, Sun X.
    J Ginseng Res; 2019 Jan; 43(1):95-104. PubMed ID: 30662298
    [Abstract] [Full Text] [Related]

  • 2. Salusin-β, but not salusin-α, promotes human umbilical vein endothelial cell inflammation via the p38 MAPK/JNK-NF-κB pathway.
    Zhou CH, Pan J, Huang H, Zhu Y, Zhang M, Liu L, Wu Y.
    PLoS One; 2014 Jan; 9(9):e107555. PubMed ID: 25210730
    [Abstract] [Full Text] [Related]

  • 3. Attenuation of TNF-α-Induced Inflammatory Injury in Endothelial Cells by Ginsenoside Rb1 via Inhibiting NF-κB, JNK and p38 Signaling Pathways.
    Zhou P, Lu S, Luo Y, Wang S, Yang K, Zhai Y, Sun G, Sun X.
    Front Pharmacol; 2017 Jan; 8():464. PubMed ID: 28824425
    [Abstract] [Full Text] [Related]

  • 4. miR-92a-3p promotes ox-LDL induced-apoptosis in HUVECs via targeting SIRT6 and activating MAPK signaling pathway.
    Xu Y, Miao C, Cui J, Bian X.
    Braz J Med Biol Res; 2021 Jan; 54(3):e9386. PubMed ID: 33470395
    [Abstract] [Full Text] [Related]

  • 5. Procyanidin B2 alleviates oxidized low-density lipoprotein-induced cell injury, inflammation, monocyte chemotaxis, and oxidative stress by inhibiting the nuclear factor kappa-B pathway in human umbilical vein endothelial cells.
    Yuan L, Fan L, Zhang Z, Huang X, Liu Q, Zhang Z.
    BMC Cardiovasc Disord; 2024 Apr 29; 24(1):231. PubMed ID: 38679696
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Notoginsenoside R1 Protects HUVEC Against Oxidized Low Density Lipoprotein (Ox-LDL)-Induced Atherogenic Response via Down-Regulating miR-132.
    Fu C, Yin D, Nie H, Sun D.
    Cell Physiol Biochem; 2018 Apr 29; 51(4):1739-1750. PubMed ID: 30504696
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. LncRNA OIP5-AS1 facilitates ox-LDL-induced endothelial cell injury through the miR-98-5p/HMGB1 axis.
    Zheng Z, Zhang G, Liang X, Li T.
    Mol Cell Biochem; 2021 Jan 29; 476(1):443-455. PubMed ID: 32990894
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Ginsenoside Compound K Attenuates Ox-LDL-Mediated Macrophage Inflammation and Foam Cell Formation via Autophagy Induction and Modulating NF-κB, p38, and JNK MAPK Signaling.
    Lu S, Luo Y, Sun G, Sun X.
    Front Pharmacol; 2020 Jan 29; 11():567238. PubMed ID: 33041808
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. MicroRNA-328-3p Protects Vascular Endothelial Cells Against Oxidized Low-Density Lipoprotein Induced Injury via Targeting Forkhead Box Protein O4 (FOXO4) in Atherosclerosis.
    Qin X, Guo J.
    Med Sci Monit; 2020 Apr 24; 26():e921877. PubMed ID: 32329448
    [Abstract] [Full Text] [Related]

  • 20. Protective effect of the silkworm protein 30Kc6 on human vascular endothelial cells damaged by oxidized low density lipoprotein (Ox-LDL).
    Yu W, Ying H, Tong F, Zhang C, Quan Y, Zhang Y.
    PLoS One; 2013 Apr 24; 8(6):e68746. PubMed ID: 23840859
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.